vimarsana.com
Home
Live Updates
China Precision Medicine Business Opportunities Databook 202
China Precision Medicine Business Opportunities Databook 202
China Precision Medicine Business Opportunities Databook 2023: Focus on Mepolizumab, Osimertinib, Aripiprazole Lauroxil, & Alectinib - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 13, 2023--
Related Keywords
China ,
Aripiprazole Lauroxil ,
Laura Wood ,
Diagnostics Companies ,
Technology Platforms ,
E St Office Hours Call ,
Biotechnology Companies ,
Office Hours Call ,
Ion Semiconductor ,
Route Of Administration ,
Healthcare It Specialists Big Data Companies ,
Topics Covered ,
Precision Medicine Market Size ,
Precision Medicine Market Share ,
Medicine Market Size ,
Cloud Based Platform ,
On Premise Platform ,
Big Data Analytics ,
Drug Discovery ,
Companion Diagnostics ,
Gene Sequencing ,
Chain Termination Sequencing ,
Nanopore Sequencing ,
Ion Semiconductor Sequencing ,
Single Molecule Real Time Sequencing ,
Infectious Diseases ,
End User ,
Big Data Companies ,
Clinical Laboratories ,
Senior Press ,
Free Call ,
Hours Call ,
Business Wire ,
Business ,
Ews Ap ,